Donaldson purchases Solaris Biotechnology

By The Science Advisory Board staff writers

November 24, 2021 -- Filtration products provider Donaldson has acquired bioprocessing equipment manufacturer Solaris Biotechnology for approximately 41 million euros ($45.9 million).

Italy-based Solaris designs and manufactures equipment such as bioreactors, fermenters, and tangential flow filtration systems for use in food and beverage, biotechnology, and other life sciences markets, according to Donaldson. Solaris is expected to generate approximately 5 million euros ($5.6 million) in revenue in 2021.

Solaris co-founder and CEO Matteo Brognoli will stay on as managing director and will be responsible for daily operations and growth of the business.

Solaris
Solaris' Porto Mantovano, Italy, location. Image courtesy of Donaldson.

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter